Gencurix KRX:229000KOSDAQ
젠큐릭스 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days4
Articles tracked1since Sep 11
In Q2 2026, Gencurix reported revenue of ₩3.0bn, up 49.3% year on year, and an operating loss of ₩702m. Gencurix (젠큐릭스) appeared in 1 Korean news article and 4 DART filings over the past seven days. Coverage peaked on Sep 14 with 1 article. The most common catalyst was risk & warnings (1).
Gencurix quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩3.0bn | +49.3% | −₩702m | −₩1.3bn |
| Q1 2026 | ₩2.1bn | +23.1% | −₩1.0bn | −₩2.4bn |
| Q4 2025 derived | ₩2.1bn | -8.9% | −₩2.1bn | −₩1.8bn |
| Q3 2025 | ₩1.7bn | +20.3% | −₩1.6bn | −₩2.0bn |
| Q2 2025 | ₩2.0bn | +255.6% | −₩1.3bn | −₩1.5bn |
| Q1 2025 | ₩1.7bn | +109.1% | −₩1.6bn | −₩2.0bn |
| Q4 2024 derived | ₩2.3bn | – | −₩1.3bn | ₩5.4bn |
| Q3 2024 | ₩1.4bn | +50.0% | −₩1.8bn | −₩2.0bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Gencurix top stories 2 weeks, by number of outlets
- 1